The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

THE OCCURRENCE OF METHEMOGLOBINEMIA DURING INSULIN COMA THERAPY

Published Online:https://doi.org/10.1176/ajp.110.2.119

Five cases of methemoglobinemia resulting from the accidental substitution of sodium nitrite for potassium citrate in the gavage mixture given to terminate insulin coma treatment are recorded. The simple and efficacious treatment by intravenous injection of methylene blue is presented.

It is speculated that further research might show that the intentional production of methemoglobinemia in nonhypoglycemic subjects would be a safe and useful method of treatment in schizophrenia.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.